Christoph A. Buhrer
Expertise in
12
conditions

Christoph A. Buhrer

GFO Kliniken Bonn
Bonn, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
12
conditions
GFO Kliniken Bonn
Bonn, NW, DE 

Overview

Christoph Buhrer practices practicing medicine in Bonn, Germany.

Mr. Buhrer is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Premature Infant, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage of the Newborn, Patent Ductus Arteriosus, and Endoscopy.

He is actively involved in clinical research, co-authoring 269 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

GFO Kliniken Bonn
Bonn, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
Enrollment Status: Recruiting
Publish Date: May 07, 2026
Intervention Type: Drug
Study Phase: Phase 2
Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial
Nasal High Frequency Oscillation Ventilation Versus Nasal Continuous Positive Airway Pressure to Reduce Post-extubation pCO2 in Very Low Birth Weight Infants: a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: August 05, 2020
Intervention Type: Device
Study Phase: Not Applicable
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants - a Randomized, Double-blind, Placebo-controlled, Prospective, and Multicenter Clinical Study
Enrollment Status: Unknown
Publish Date: November 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trial

269 Total Publications

Dexmedetomidine Preserves Hippocampal Neurogenesis During Recovery from Neonatal Hyperoxia in Rats.
Dexmedetomidine Preserves Hippocampal Neurogenesis During Recovery from Neonatal Hyperoxia in Rats.
Journal: Cells
Published: April 28, 2026

Frequently Asked Questions about Christoph A. Buhrer

Is Christoph A. Buhrer a top-rated expert for Premature Infant?

MediFind is an objective health platform that identifies experts based on real-world data. Christoph A. Buhrer is classified as an Elite expert for Premature Infant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christoph A. Buhrer participate in research or clinical trials?

Yes. Christoph A. Buhrer has published 269 articles and abstracts on conditions like Premature Infant. You can view a list of Christoph A. Buhrer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Buhrer's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 63 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile